SAR-Co-V-2 Assay
The SAR-Co-V-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider.
Availability: Commercially Available
+1 855 362 5221
8161 Maple Lawn Boulevard, Suite 375
Fulton, MD 20759
USA
|
|
www.biocerna.com
| Manufacturer |
| Biocerna LLC |
| Product Name |
| SAR-Co-V-2 Assay |
| Detection Category |
| Biological |
| Detection Principle |
| Molecular; |
| Detection Method |
| Assays;Nucleic Acid Amplification; |
| Application |
| Diagnostics; |
| Equipment Type |
| Diagnostic |
| Product Synopsis |
| The SAR-Co-V-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| April 2020 |
| User Feedback Sources |
| Indifferent/No user feedback |
| No Information Is Available |
| Transportability |
| Handheld |
| Other Biological Targets |
| SARS-CoV-2 |
| Sample Introduction |
| Liquid; |
| Training Required |
| <1 day training |